TLCD3B and Alzheimer disease: Inhibition of the ceramide synthesis by SPTLC-1 siRNA decreased the UPRmt related proteins levels in SHSY5Y cells treated with Aβ25–35 transiently, which provides evidence for an involvement of ceramide synthase SPTLC-1 in the activation of UPRmt response in AD cell models.